In a report released on April 11, Salveen Richter from Goldman Sachs maintained a Buy rating on Regeneron (REGN – Research Report), with a ...

GSK's (GSK) stock rises as the company's Arexvy shot could see expanded CDC recommendations for RSV protection in at-risk adults aged 50-59 this week. Read more here.

US stocks saw choppy trading on Tuesday (April 15) as investors digested a new round of first-quarter earnings reports and ...

"It's early to call heads or tails or direction of travel on how this will play out," CEO David Solomon said of Washington's ...

Goldman Sachs beat first-quarter profit estimates as its traders capitalized on volatile markets to bring in record equities ...

Goldman Sachs reported revenue drops in two of its three main business lines, but trading revenue was enough to satisfy ...

Goldman Sachs cashed in on stock market turmoil over President Donald Trump’s tariffs — with the bank’s stock traders bagging ...

Goldman Sachs (NYSE:GS) reported higher first-quarter results, with revenue of $15.06 billion beating expectations at $14.81 ...

By Rob Copeland Goldman Sachs on Monday revealed its latest financial results and outlook for the future, and in a deft feat of linguistics, its executives managed not to utter the word “tariff ...